Cognito Therapeutics
Last verified 2026-05-19. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $314.5Mattributed |
|---|---|
| Latest round | series-d+, $105.0M, 2026-03-01attributed |
| Founded | 2016 |
| Headquarters | Cambridge, USA |
| Industry | bio |
| Stage | series-b+ |
| Website | cognitotx.com |
Cognito Therapeutics' Spectris is a non-invasive headset that uses audiovisual stimulation to evoke gamma brain wave activity in Alzheimer's patients. It targets people with cognitive decline who use it one hour daily at home. The device holds FDA Breakthrough Device Designation, a non-pharmaceutical approach to slowing neurodegeneration.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-03-01 | series-d+ | $105.0M | undisclosed |
Detected tech stack
Cloudflare, AitThemes, Lenis 1.0.29, Unpkg, Google Tag Manager, jsDelivr, DoubleClick Floodlight, cdnjs, Webflow, WordPress, PHP, MySQL
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series D+, $105.0M | attributed | crunchbase named as publisher. No document URL on file. |
| Total raised $314.5M | attributed | crunchbase named as publisher. No document URL on file. |
| Company existence | self-reported | cognitotx.com, read 2026-05-19 |
| Description | self-reported | cognitotx.com, read 2026-05-19 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.